Cell-free DNA for detection and monitoring of extramedullary AML relapse. - Hupe HC; Wienecke CP; Bartels S; Schipper E; Leßmann J; Lasch A; Bader M; Gabdoulline R; Neugebohren M; Dammann E; Kreipe HH; Lehmann U; et al. (HemaSphere, 2025)